Cafepharma Today

May 28 2025 - GLP-1 prescriptions for weight loss soar, despite obstacles
GLP-1 prescriptions for weight loss soar, despite obstacles
FDA approves use of Sanofi's meningococcal vaccine in infants
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck wins approval for extended release Janumet
Boston Globe, MA
Friday, February 3, 2012 - 9:48am
tags:
Merck, Janumet XR, diabetes
Gilead Sciences 4Q profit rises on HIV drug sales
Yahoo/AP
Friday, February 3, 2012 - 9:47am
tags:
earnings, HIV, Gilead
Vertex Pharma reports 4th-quarter profit as sales of hepatitis C drug Incivek reach $456.8M
Yahoo/AP
Friday, February 3, 2012 - 9:46am
tags:
Vertex, hepatitis C, Incivek, earnings
Dr. Reddy’s Q3 FY12 Financial Results: Highest Ever Quarterly Sales and Profit
Yahoo
Friday, February 3, 2012 - 9:45am
tags:
earnings, Dr Reddy's
Are WuXi PharmaTech and ShangPharma M&A Targets?
Seeking Alpha
Thursday, February 2, 2012 - 3:00pm
tags:
China, M&A, WuXi PharmaTech, ShangPharma
Gilead Stock, In Top Group, Slips Before Earnings
Investors.com
Thursday, February 2, 2012 - 11:56am
tags:
Gilead, earnings
Novartis Gets Criticized Over Vasella Compensation
Pharmalot
Thursday, February 2, 2012 - 11:52am
tags:
Daniel Vasella, executive pay, Novartis
Top Canada Court Denies Pfizer Appeal over Apotex Glaucoma Drug
Bloomberg
Thursday, February 2, 2012 - 11:49am
tags:
Canada, Apotex, Pfizer, glaucoma
FDA panel to discuss Arena obesity drug in 2nd quarter
Reuters
Thursday, February 2, 2012 - 11:06am
tags:
Arena, FDA, obesity, lorcaserin
Biogen Idec: The Patriots of Biotechs
PharmExec
Thursday, February 2, 2012 - 11:06am
tags:
Biogen Idec, Tysabri, Elan, biotech, BG-12, MS, multiple sclerosis
Glaxo Settles 20,000 Lawsuits Over Avandia, Lawyer Says
Bloomberg Businessweek
Thursday, February 2, 2012 - 11:02am
tags:
settlements, GSK, diabetes, Avandia
Lilly Alzheimer's drug an unlikely ace in the hole
Reuters
Thursday, February 2, 2012 - 11:01am
tags:
Eli Lilly, Alzheimer's disease, Pfizer, solanezumab
Allergan Inc. Earnings: Margins Expand Again, Profit Rises
Yahoo/Wall St Cheat Sheet
Thursday, February 2, 2012 - 10:56am
tags:
earnings, Allergan
Pharma defeats biotech push for rapid approval program
Fierce Biotech
Thursday, February 2, 2012 - 10:11am
tags:
GSK, Biotechnology Industry Organization, drug approvals
New CEO = Dendreon Takeover Target?
Motley Fool
Thursday, February 2, 2012 - 10:09am
tags:
Dendreon, M&A, Pharma CEOs, Savient, John Johnson
Sucampo's Lubiprostone meets primary endpoint in Phase 3 clinical trial for OBD
Yahoo/Fly on the Wall
Thursday, February 2, 2012 - 10:08am
tags:
Sucampo, Lubiprostone, OBD, opioid-induced bowel dysfunction
Novo Nordisk Q4 profits jump, outlook raised
Yahoo/AP
Thursday, February 2, 2012 - 10:06am
tags:
earnings, Novo Nordisk
Merck & Co. swings to Q4 profit on lower charges and 1.6 percent growth in sales
Yahoo/AP
Thursday, February 2, 2012 - 9:15am
tags:
Merck, earnings
AB Soars 46% as Cancer Drug Beats Pfizer’s Sutent: Paris Mover
Bloomberg
Thursday, February 2, 2012 - 9:15am
tags:
Pfizer, Sutent, AB Science, masitinib, gastrointestinal cancer
AstraZeneca to cut 7,300 jobs, post lower profit
Marketwatch
Thursday, February 2, 2012 - 9:13am
tags:
layoffs, AstraZeneca, guidance

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.